• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
SPCL logo

Stanford Psychedelic Consciousness Lab

  • Home
  • People
  • Research
    • Ibogaine for TBI and PTSD
    • Neuromodulating Hypnotizability
    • Targeted Ketamine Delivery
  • Why Psychedelics?
  • Publications
  • In the News
  • Support Our Research
  • Contact Us

  • Home
  • People
  • Research
    • Ibogaine for TBI and PTSD
    • Neuromodulating Hypnotizability
    • Targeted Ketamine Delivery
  • Why Psychedelics?
  • Publications
  • In the News
  • Support Our Research
  • Contact Us
TwitterFacebook

Research

Ongoing Research

Exploring the Therapeutic Potential of Ibogaine for PTSD and TBI: A Groundbreaking Research Study

Ibogaine’s unique pharmacological properties and reported anecdotal benefits have generated significant interest. We have completed data collection for a study aimed at uncovering the promising therapeutic applications of Ibogaine for individuals suffering from Traumatic Brain Injury (TBI) and Post-Traumatic Stress Disorder (PTSD) symptoms.


Neuromodulating Hypnotizability

We completed data collection for a study testing the ability to increase responsiveness to hypnosis (hypnotizability) using noninvasive brain stimulation. We developed a personalized, neuroimaging-based targeting method using an individual’s brain structure and function, tracing a neural pathway involved in hypnotizability.


Neuroimaging-Guided Targeted Ketamine Delivery using Transcranial Focused Ultrasound

We are scheduled to embark on a unique first-in-human interdisciplinary study, to use targeted delivery of psychoactive compounds to specific brain regions, guided by personalized neuroimaging and utilizing noninvasive brain stimulation.


Primary Sidebar

Footer

Stanford Medicine logo

Make a Gift      More Information »

© Copyright 2023 Stanford University. All rights reserved.

Twitter Facebook

  • Home
  • People
  • Research
    ▼
    • Ibogaine for TBI and PTSD
    • Neuromodulating Hypnotizability
    • Targeted Ketamine Delivery
  • Why Psychedelics?
  • Publications
  • In the News
  • Support Our Research
  • Contact Us